TP53 and melanoma: Given that these alterations in p53-dependent death pathways are reversible and restoration of, for example, Apaf-1 by treatment with the methylation inhibitor 5-aza-2'-deoxycytidine could rescue the observed apoptotic defects [10], reversing epigenetic changes may lead to a targeted therapy of advanced melanomas.